Analysis of TP53 gene expression and p53 level of human hypopharyngeal FaDu (HTB-43) head and neck cancer cell line after microRNA-181a inhibition

Genetics and Molecular Research

Volumn 13, Issue 1, 2014, Pages 1679-1683

  Cheah, Y K ^a   Cheng, R W ^a   Yeap, S K ^a   Khoo, C H ^a   See, H S ^b  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b Forensic Services (M) Sdn Bhd   (Malaysia)

Author keywords

Head and neck cancer; miRNA 181a; p53

Indexed keywords

MICRORNA; MICRORNA 181A; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL LEVEL; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC ANALYSIS; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HYPOPHARYNX CANCER; PROTEIN CONTENT; PROTEIN RNA BINDING; PROTEIN SYNTHESIS REGULATION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MICRORNAS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84897557707     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.January.22.4     Document Type: Article

References (18)

1. Argiris A, Karamouzis MV, Raben D and Ferris RL (2008). Head and neck cancer. Lancet 371: 1695-1709.
2. Chien CY, Huang CC, Cheng JT, Chen CM, et al. (2003). The clinicopathological significance of p53 and p21 expression in squamous cell carcinoma of hypopharyngeal cancer. Cancer Lett. 201: 217-223.
3. Esquela-Kerscher A and Slack FJ (2006). Oncomirs-microRNAs with a role in cancer. Nat. Rev Cancer 6: 259-269.
4. Hui AB, Lenarduzzi M, Krushel T, Waldron L, et al. (2010). Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin. Cancer Res. 16: 1129-1139.
5. Liu X, Chen Z, Yu J, Xia J, et al. (2009). MicroRNA profiling and head and neck cancer. Comp. Funct. Genomics 837514.
6. -ΔΔCT Method. Methods 25: 402-408.
7. Miyachi M, Kakazu N, Yagyu S, Katsumi Y, et al. (2009). Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells. Clin. Cancer Res. 15: 4077-4084.
8. Morris SM (2002). A role for p53 in the frequency and mechanism of mutation. Mutat. Res. 511: 45-62.
9. Nurul-Syakima AM, Yoke-Kqueen C, Sabariah AR, Shiran MS, et al. (2011). Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers. Int. J. Mol. Med. 28: 327-336.
10. Rezende TM, de Souza FM and Franco OL (2010). Head and neck cancer: proteomic advances and biomarker achievements. Cancer 116: 4914-4925.
11. Schaaij-Visser TB, Brakenhoff RH, Leemans CR, Heck AJ, et al. (2010). Protein biomarker discovery for head and neck cancer. J. Proteomics 73: 1790-1803.
12. Schmittgen TD and Livak KJ (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3: 1101-1108.
13. Seoudi AM, Lashine YA and Abdelaziz AI (2012). MicroRNA-181a-a tale of discrepancies. Expert. Rev. Mol. Med. 14: e5.
14. Shi L, Cheng Z, Zhang J, Li R, et al. (2008). hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res. 1236: 185-193.
15. Tran N, McLean T, Zhang X, Zhao CJ, et al. (2007). MicroRNA expression profiles in head and neck cancer cell lines. Biochem. Biophys. Res. Commun. 358: 12-17.
16. Twu CW, Jiang RS, Shu CH and Lin JC (2006). Association of p53 codon 72 polymorphism with risk of hypopharyngeal squamous cell carcinoma in Taiwan. J. Formos. Med. Assoc. 105: 99-104.
17. Wang X, Gocek E, Liu CG and Studzinski GP (2009). MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1, 25-dihydroxyvitamin D3. Cell Cycle 8: 736-741.
18. Zamai L, Canonico B, Gritzapis A, Luchetti F, et al. (2002). Intracellular detection of Bcl-2 and p53 proteins by flow cytometry: comparison of monoclonal antibodies and sample preparation protocols. J. Biol. Regul. Homeost. Agents 16: 289-302.